Coronary computed tomographic angiography quantitative plaque analysis improves detection of early cardiac allograft vasculopathy: A pilot study.
Cardiac allograft vasculopathy (CAV) is an increasingly important complication following cardiac transplant. We assessed the additive diagnostic benefit of quantitative plaque analysis in patients undergoing coronary computed tomographic angiography (CCTA). Consecutive patients undergoing CCTA for CAV surveillance were identified. Scans were visually interpreted for coronary stenosis. Semi-automated software was used to quantify non-calcified plaque (NCP), as well as its components. Optimal diagnostic cut-offs for CAV, with coronary angiography as gold-standard, were defined using receiver operating characteristic curves. In total 36 scans were identified in 17 patients. CAV was present in 17 (46.0%) reference coronary angiograms, at a median of 1.9 years prior to CCTA. Median NCP (147 vs. 58, p<0.001), low-density NCP (median 4.5 vs. 0.9, p=0.003), fibrous plaque (median 76.1 vs 31.1, p=0.003) and fibro-fatty plaque (median 63.6 vs. 27.6, p<0.001) volumes were higher in patients with CAV, while calcified plaque was not (median 0.0 vs 0.0, p=0.510). Visual assessment of CCTA alone was 70.6% sensitive and 100% specific for CAV. Addition of total NCP volume increased sensitivity to 82.4%, while maintaining 100% specificity. NCP volume is significantly higher in patients with CAV. Addition of quantitative analysis to visual interpretation improves the sensitivity for detecting CAV without reducing specificity.